Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision label v3.4.2 appears and v3.4.1 is removed on the history page; no substantive study data or functionality is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows a new revision label (v3.4.1) replacing v3.4.0. This is a minor metadata update and does not change study data or content.SummaryDifference0.1%

- Check27 days agoChange DetectedThe Record History page adds a 'Show glossary' option and uses green highlights for additions and red highlights for deletions to indicate changes; revision notes show a new version v3.4.0 and adjust the wording of the FEAR Act data line.SummaryDifference1%

- Check42 days agoChange DetectedThe Record History now includes a new revision entry v3.3.4 and removes v3.3.3, reflecting internal version tracking. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure item. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and a deleted revision entry (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.